Literature DB >> 10605735

Heparin-induced thrombocytopenia: a clinicopathologic syndrome.

T E Warkentin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10605735

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  26 in total

Review 1.  Laboratory testing for heparin-induced thrombocytopenia.

Authors:  T E Warkentin
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

2.  Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.

Authors:  Lubica Rauova; Jessica D Hirsch; Teshell K Greene; Li Zhai; Vincent M Hayes; M Anna Kowalska; Douglas B Cines; Mortimer Poncz
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

3.  Mesenteric and coeliac occlusions following heparin-induced thrombocytopenia after aortobiprofunda bypass surgery.

Authors:  Ewan Bigsby; Arindam Chaudhuri; Alastair Whiteway
Journal:  Ann R Coll Surg Engl       Date:  2010-01       Impact factor: 1.891

4.  Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.

Authors:  Kristin M Bompiani; Jens L Lohrmann; George A Pitoc; James W Frederiksen; George B Mackensen; Bruce A Sullenger
Journal:  Chem Biol       Date:  2014-07-24

5.  Recurrent venous thrombosis following free flap surgery: The role of heparin-induced thrombocytopenia.

Authors:  Andreas Nikolis; Apostolos Christopoulos; Michel Saint-Cyr; Carlos Cordoba; Louis Guertin; Patrick G Harris
Journal:  Can J Plast Surg       Date:  2003

6.  Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system.

Authors:  Esther A Obeng; Kathy M Harney; Thomas Moniz; Alana Arnold; Ellis J Neufeld; Cameron C Trenor
Journal:  J Pediatr       Date:  2014-10-14       Impact factor: 4.406

7.  Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.

Authors:  Eric Pautas; Isabelle Gouin; Oliver Bellot; Jean-Paul Andreux; Virginie Siguret
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.

Authors:  Jovan Perunicic; Nebojsa M Antonijevic; Predrag Miljic; Valentina Djordjevic; Danijela Mikovic; Mirjana Kovac; Milan Djokic; Igor Mrdovic; Aleksandra Nikolic; Zorana Vasiljevic
Journal:  J Thromb Thrombolysis       Date:  2007-09-09       Impact factor: 2.300

Review 9.  Heparin induced thrombocytopenia: diagnosis and management update.

Authors:  I Ahmed; A Majeed; R Powell
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

10.  Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.

Authors:  Nicole L Whitlatch; Stephanie L Perry; Thomas L Ortel
Journal:  Thromb Haemost       Date:  2008-10       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.